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Abstract 17 
Background & aim: Lifestyle changes focusing on diet and exercise remain the cornerstone of the 18 
treatment of non-alcoholic fatty liver disease (NAFLD). The present co-twin control study of 19 
monozygotic (MZ) twin pairs was designed to identify nutritional factors potentially involved in the 20 
pathogenesis of NAFLD. 21 
Methods: Cross-sectional study of 50 MZ twin pairs (age range: 23-36 years), of which ten pairs were 22 
discordant for liver fat (liver fat percentage of one twin ≤ 5% and his/her co-twin > 5% and a 23 
difference between co-twins of > 5%) as determined by magnetic resonance spectroscopy. Nutrient 24 
intake was calculated from 3-day food records. 25 
Results: Among the ten liver fat-discordant twin pairs, the n-6: n-3 ratio was significantly higher in 26 
the twins with higher liver as compared to their co-twins with lower liver fat (6.6: 1 vs. 3.2: 1, p-value 27 
= 0.005). In multiple regression analysis of within-pair differences including all 50 twin pairs, a 28 
higher n-6: n-3 ratio was significantly associated with a higher liver fat percentage within MZ twin 29 
pairs after adjustment for body mass index, energy intake and other covariates (standardized beta= 30 
0.43, p-value = 0.001). 31 
Conclusions: Our findings suggest that the n-6: n-3 ratio is a promising dietary agent for the 32 
prevention and treatment of NAFLD. Clinical trials are required to better understand causal 33 






Non-alcoholic fatty liver disease (NAFLD), characterized by fat accumulation in more than 5% of 37 
hepatocytes in the absence of excessive alcohol consumption, is the most common chronic liver 38 
disease in the world. It affects up to a quarter of the general population, depending on the country 39 
studied1. The disease spectrum includes simple steatosis, steatohepatitis, advanced fibrosis and 40 
cirrhosis which can progress to liver failure1.  41 
The heritability of NAFLD is low, underscoring the importance of environmental factors in its 42 
etiology2. Currently, there are no approved pharmacotherapies for patients with NAFLD. Therefore, 43 
weight reduction and lifestyle changes through diet and exercise form the first-line therapy for 44 
treatment3. Diets high in saturated fatty acids and refined carbohydrates could exacerbate NAFLD4, 45 
while Mediterranean dietary patterns might reduce liver fat even in the absence of weight loss5. 46 
Randomized controlled trials suggest that supplementation with omega-3 (n-3) polyunsaturated fatty 47 
acids (PUFAs) has therapeutic potential for treating patients with NAFLD 6.  48 
Another powerful study design that allows stronger inference about causality than observational 49 
studies of unrelated individuals is the co-twin-control design of disease-discordant monozygotic 50 
(MZ) twin pairs because MZ twins are genetically identical at the DNA sequence level and 51 
discordance within pairs must thus be of environmental origin. Our previous twin study suggests that 52 
metabolic abnormalities in acquired obesity are tightly linked to liver fat content7. The present study 53 
of MZ twins was designed to identify nutritional factors potentially involved in the pathogenesis of 54 
NAFLD.  55 
Research design and methods 56 
TwinFat study participants were enrolled from two Finnish population-based longitudinal studies of 57 
five consecutive birth cohorts of young adult twins8. Participants were invited to the TwinFat study 58 
based on their reported body mass index (BMI) during these studies (at the age of 23 to 27 years) 59 
with the aim to represent a wide range of intra-pair differences in BMI. Participants were then 60 
weighed and their height was measured while barefoot and in light clothing by trained research 61 
nurses. Whole-body fat was measured by dual energy x-ray absorptiometry, abdominal 62 
subcutaneous and intra-abdominal fat by magnetic resonance imaging and liver fat percentage by 63 
magnetic resonance spectroscopy as described earlier9. The homeostasis model assessment of 64 
insulin resistance (HOMA-IR) was calculated based on 2-hour oral glucose tolerance tests. Fasting 65 
plasma cholesterol and triglyceride concentrations were determined with enzymatic methods. 66 
Supine blood pressure was measured using an automatic digital sphygmomanometer (mean of three 67 
measurements).  68 
Nutrient intake was calculated from 3-day food records by the Diet32 program (Aivo), based on a 69 
national Finnish database (Fineli, www.fineli.fi, National Institute for Health and Welfare, Nutrition 70 
Unit, Helsinki, Finland). The sports activity index was calculated from the Baecke questionnaire10. 71 
Out of 107 twin individuals with data on liver fat and food records, one twin individual was excluded 72 
because of missing information on physical activity, two twin individuals because of implausible 73 
energy intakes (one woman reported < 714 kcal/day, and one men > 4200 kcal/day) and another four 74 
twin individuals because of missing co-twin information. Thus, the final analytic sample consisted of 75 
50 MZ twin pairs, of which 10 twin pairs were discordant for liver fat. Liver fat discordance was 76 
defined as the liver fat percentage of one twin ≤ 5% and his/her co-twin > 5% and a difference between 77 
co-twins of > 5% resulting in identification of ten such pairs. The study protocol was in accordance 78 
with the Helsinki Declaration and approved by local Ethical Committees. Written informed consent 79 




Data were reported as median and interquartile ranges. Differences between discordant twin pairs 81 
were analysed using Wilcoxon signed rank test. In all twin pairs, multiple linear regression analysis 82 
was used to relate within-pair differences in log transformed liver fat to within-pair differences in the 83 
omega-6 (n-6) to n-3 ratio adjusted for covariates. Statistical analyses were performed using 84 
Stata version 13 (Stata Corp, College Station, TX). 85 
Results 86 
The descriptive characteristics (clinical, behavioral, nutritional and liver fat) of the 100 twin 87 
individuals (mean age 29.9 years (range: 23-36 years) and of the subset of ten liver fat-discordant 88 
twin pairs are shown in Table 1. Among these ten pairs, the twins with higher liver fat had more body 89 
fat and a worse metabolic profile than their co-twins with lower liver fat. The twins with higher and 90 
lower liver fat did not differ in physical activity indices and energy intake, or the intake of protein, 91 
fat and carbohydrates. In every single discordant pair, the twin with the higher liver fat percentage 92 
had consistently a higher n-6: n-3 ratio than his or her co-twin with less liver fat (Supplementary 93 
Figure). The twins with the lower liver fat percentage had a mean n-6: n-3 ratio of 3.2: 1, while the 94 
ratio in the co-twins with higher liver fat percentage was 6.6: 1 (p-value = 0.005 for the difference 95 
between pairs). 96 
The results from the within-pair linear regression on all 50 MZ pairs are presented in Table 2. The n-97 
6: n-3 ratio and BMI were significant predictors and of about equal importance in predicting within-98 
pair differences in liver fat. The gender interaction (male vs. female pairs) was not significant. 99 
Additional adjustment for intra-abdominal fat (standardized beta= 0.37, p=0.08) did not change the 100 
effect estimate for the n-6: n-3 ratio (standardized beta= 0.39, p-value = 0.002), but removed the 101 
influence of BMI (standardized beta= 0.13, p-value = 0.52). In a model that additionally adjusted for 102 
sucrose, the effect size for sucrose was not significant (standardized beta= -0.12, p-value = 0.28), and 103 
the effect estimate for the n-6: n-3 ratio remained unchanged (standardized beta= 0.40, p-value = 104 
0.001). 105 
Discussion 106 
To our knowledge, this is the first study that evaluated nutrient intake differences in MZ twin pairs 107 
discordant for liver fat. Among the 10 twin pairs discordant for liver fat, the co-twins with higher 108 
liver fat reported a higher dietary n-6: n-3 ratio than his or her co-twin in every single pair. We 109 
employed the MZ co-twin control design, which is analogue to a case-control study, where the twin 110 
with the higher liver fat is the case and the co-twin with the lower liver fat the control, with the 111 
additional advantage that cases and controls are naturally matched for several factors including age, 112 
sex and genotype.  113 
Due to modern agriculture and the popularity of fast foods, Western diets contain excessive amounts 114 
of n-6 PUFAs and low amounts of n-3 PUFAs. An overconsumption of n-6 PUFAs coupled with 115 
under-consumption of n-3 PUFAs may lead to inflammation and pro-inflammatory cytokine 116 
production involved in many disease processes11. In addition, n-3 PUFAs may influence the intestinal 117 
microbiota12 and thereby modulate NAFLD susceptibility. Recent meta-analysis of randomized 118 
controlled trials suggest that n-3 PUFA supplementation can reduce liver fat and glucose control in 119 
patients with NAFLD, at amounts that can be easily obtained through the habitual diet6.  120 
In the present study of liver-fat discordant MZ twin pairs, a mean n-6: n-3 ratio of 3.2: 1 was 121 
associated with normal liver fat content, while a mean ratio of 6.6: 1 was associated with increased 122 
liver fat content independent of genetic and familial confounding factors. Dietary advice for 123 




(such as refined vegetable oils rich in n-6 fatty acid used for deep frying) towards fresh foods (such 125 
as vegetable oils used in salads), and by increasing fish intake while decreasing meat intake11. Our 126 
findings could have important implications for the dietary management of NAFLD and encourage 127 
clinical trials to better understand causal relationships and required doses. 128 
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Table 1. Clinical characteristics, physical activity and macronutrient intakes of the monozygotic twins  
 
 
All twins  
Twin pairs discordant for liver fat (within-
pair difference in liver fat > 5%)1 
 
 Co-twins with liver 
fat ≤ 5%  
Co-twins with liver 
fat > 5% 
p-
value2 
Demographic factors     
  Number (n) of individuals3 100 10 10  
  Males (n) 46 6 6  
  Liver fat >5%  (n) 22 0 10  
  Liver fat (%)4 1.0 (0.5, 3.9) 1.1 (0.8, 3.2) 9.4 (7.3, 9.4)  
Clinical parameters4     
  BMI (kg/m2 ) 26.6 (23.7, 29.8) 25.7 (22.9, 27.8) 31.8 (27.6, 35.0) 0.005 
  Body fat (%) 32.4 (26.9, 40.7) 27.7 (21.2, 38.8) 38.3 (31.9, 43.4) 0.007 
  Intra-abdominal fat (dm3) 807 (422, 1355) 604 (439, 11165) 1709 (1416, 2417) 0.007 
  Subcutaneous fat (dm3) 3727 (2449, 5513) 3263 (2150, 5498) 5768 (3195, 6965) 0.007 
  LDL-cholesterol (mmol/l) 2.7 (2.3, 3.2) 2.7 (2.5, 2.9) 3.3 (2.7, 3.8) 0.07 
  HDL-cholesterol (mmol/l) 1.4 (1.2, 1.7) 1.5 (1.3, 1.7) 1.2 (1.1, 1.4) 0.02 
  Triglycerides (mmol/l) 1.0 (0.7, 1.3) 0.7 (0.5, 1.1) 1.3 (1.0, 2.2) 0.01 
  HOMA-IR index 1.4 (0.8, 2.0) 1.1 (0.5, 1.8) 2.4 (1.8, 2.8) 0.01 
  Systolic blood pressure (mmHg) 124 (118, 138) 131 (122, 140) 139 (124, 148) 0.36 
  Diastolic blood pressure (mmHg) 70 (65, 80) 70 (70, 78) 79 (70, 80) 0.18 
Physical activity4     
  Sports activity index 2.8 (2.3, 3.5) 3.3 (2.3, 4) 2.4 (1.8, 3.5) 0.33 
  Leisure time activity index 2.8 (2.5, 3.3) 2.8 (2.5, 3.0) 2.9 (2.5, 3.3) >0.99 
  Work activity index 2.5 (2.0, 3.3) 2.3 (2.1, 3.0) 2.6 (1.9, 2.9) 0.14 
Total energy intake (kcal) 4  2075 (1774, 2551) 2169 (1809, 2382) 2611 (2319, 2800) 0.07 
Macronutrient intake (% energy intake)4    
   Carbohydrates   43.1 (38.3, 48.1) 43.5 (37.9, 50.0) 37.4 (33.4, 44.0) 0.09 
   Protein  16.5 (14.8, 18.8) 18.0 (14.2, 22.9) 16.0 (14.1, 18.9) 0.24 
   Total fat  35.2 (30.6, 39.0) 32.4 (26.3, 38.9) 39.0 (31.6, 42.8) 0.11 
   Sucrose  9.7 (6.0, 13.0) 4.8 (3.8, 7.0) 8.8 (7.9, 11.2) 0.04 
   Saturated fatty acids   13.5 (11.1, 16.2) 11.3 (10.9, 13.8) 13.1 (10.7, 16.3) 0.58 
   Monounsaturated fatty acids  10.6 (9.0, 12.3) 8.8 (7.4, 12.8) 12.0 (9.6, 13.4) 0.24 
   Polyunsaturated fatty acids  4.5 (3.8, 5.8) 4.1 (3.5 5.5) 5.6 (4.8, 5.8) 0.09 
Omega-6/omega-3 ratio4 4.8 (3.0, 6.1) 3.2 (2.3, 5.4) 6.6 (3.8, 7.4)  0.005 
Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; HDL, high -density lipoprotein; 
HOMA-IR, homeostasis model assessment of insulin resistance 
1Discordance was defined as the liver fat percentage of one twin ≤ 5% and the liver fat percentage of his/her 
co-twin > 5% and a within-pair difference in liver fat of > 5%. The difference in liver fat percentage between 
discordant co-twins ranged from 5 to 20%. 
2P-values are from Wilcoxon signed rank test comparing co-twins discordant for liver fat. 
3The 100 monozygotic twin individuals are from 50 complete twin pairs of which 10 twin pairs are 
discordant for liver fat.  




Table 2. Multiple linear regression analysis predicting (log transformed) liver fat within 50 pairs of 
monozygotic twins 
 
Dependent variable: Within-pair 
difference (Δ) in log liver fat 








Sex (Female twin pairs)  -0.57 0.23 -0.31 0.017 
Age of the twin pairs (years) -0.02 0.02 -0.09 0.42 
Δ Omega-6/omega-3 ratio 0.24 0.06 0.43 0.001 
Δ Total energy intake (per 100 
kcal) 
0.00 0.02 -0.02 0.83 
Δ Body mass index (kg/m2 ) 0.10 0.03 0.42 0.003 
Δ Alcohol intake (% energy 
intake) 
-0.02 0.02 -0.12 0.30 
Δ Sports activity index -0.14 0.10 -0.17 0.17 
R
2







Supplementary Figure. Omega-6/omega-3 ratio in ten monozygotic twin pairs discordant for liver fat  
 
 
